These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Diagnosis and therapy of heart failure with normal ejection fraction]. Schaefer HH; Dieterle T Ther Umsch; 2011 Feb; 68(2):81-7. PubMed ID: 21271538 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic impact of heart failure with preserved versus reduced ejection fraction in patients with mild symptoms]. Jung P; Huber T; Müller M; König A; Krötz F; Sohn HY Dtsch Med Wochenschr; 2012 Apr; 137(14):706-10. PubMed ID: 22454198 [TBL] [Abstract][Full Text] [Related]
4. [Diastolic heart failure: myth or fact?]. Conti L; Lerch R; Perrier A Rev Med Suisse; 2008 Oct; 4(175):2192-4, 2196-7. PubMed ID: 19024572 [TBL] [Abstract][Full Text] [Related]
5. Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults. Alagiakrishnan K; Banach M; Jones LG; Datta S; Ahmed A; Aronow WS Ann Med; 2013 Feb; 45(1):37-50. PubMed ID: 22413912 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic management of heart failure with preserved ejection fraction. Huang D; Cheng JW Ann Pharmacother; 2010 Dec; 44(12):1933-45. PubMed ID: 21098754 [TBL] [Abstract][Full Text] [Related]
8. [Heart failure with preserved ejection fraction (diastolic heart failure)]. Czuriga I; Borbély A; Czuriga D; Papp Z; Edes I Orv Hetil; 2012 Dec; 153(51):2030-40. PubMed ID: 23248058 [TBL] [Abstract][Full Text] [Related]
9. Echocardiographic Evaluation of Diastolic Function Is of Limited Value in the Diagnosis and Management of HFpEF. Vaidya GN; Abramov D J Card Fail; 2018 Jun; 24(6):392-396. PubMed ID: 29499321 [No Abstract] [Full Text] [Related]
10. Diastolic heart failure in elderly: the prognostic factors and interventions regarding heart failure with preserved ejection fraction. Acikel S; Akdemir R; Kilic H; Yesilay AB; Dogan M; Cagirci G Int J Cardiol; 2010 Feb; 138(3):311-3. PubMed ID: 18845346 [TBL] [Abstract][Full Text] [Related]
15. Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis. Glezeva N; Voon V; Watson C; Horgan S; McDonald K; Ledwidge M; Baugh J J Card Fail; 2015 Feb; 21(2):167-77. PubMed ID: 25459685 [TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF). Yamamoto K; Origasa H; Hori M; Eur J Heart Fail; 2013 Jan; 15(1):110-8. PubMed ID: 22983988 [TBL] [Abstract][Full Text] [Related]
17. Heart failure with preserved ejection fraction - coming to terms with an oxymoron. Macdonald PS Med J Aust; 2010 Jan; 192(1):4-5. PubMed ID: 20047538 [No Abstract] [Full Text] [Related]
18. Repolarization heterogeneity, diastolic dysfunction, and cardiovascular outcomes in heart failure with preserved ejection fraction. Prenner SB; Oskouie S; Shah SJ; Sauer AJ Int J Cardiol; 2016 Nov; 223():116-117. PubMed ID: 27537735 [No Abstract] [Full Text] [Related]
19. Pulsatile hemodynamics in patients with exertional dyspnea: potentially of value in the diagnostic evaluation of suspected heart failure with preserved ejection fraction. Weber T; Wassertheurer S; O'Rourke MF; Haiden A; Zweiker R; Rammer M; Hametner B; Eber B J Am Coll Cardiol; 2013 May; 61(18):1874-83. PubMed ID: 23500307 [TBL] [Abstract][Full Text] [Related]